Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intracellular proteins with metal-chelating residues refers to a broad class of proteins that possess amino acid side chains, such as histidine, cysteine, aspartate, or glutamate, capable of coordinating metal ions like iron, copper, or zinc (UniProt, 2024). These proteins play critical roles in cellular processes including enzymatic catalysis, structural stability, and metal ion homeostasis (PubMed, 2023). In a pharmacological context, this term is often used to describe the collective target of intracellular chelating agents like dexrazoxane (DrugBank, DB00380). By binding to the metal ions associated with these proteins, such drugs prevent the formation of toxic metal-drug complexes, such as iron-anthracycline complexes, and the subsequent generation of reactive oxygen species (StatPearls, NBK559245). This mechanism is primarily utilized to mitigate oxidative stress-induced damage, such as the cardiotoxicity associated with certain chemotherapeutic agents (NIH, 2023). Consequently, while not a single molecular entity, these proteins represent a significant site for therapeutic intervention in managing metal-mediated toxicity and oxidative injury.
Chelation of intracellular metal ions (primarily iron) to prevent the formation of metal-anthracycline complexes and subsequent reactive oxygen species (ROS) generation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intracellular proteins with metal-chelating residues.